机构：[1]Department of Hematology, Qilu Hospital, Shandong University, Jinan 250012, China[2]General Hospital of Ningxia Medical University, Yinchuan, China[3]Xiangya Hospital, Centre South University, Changsha, China[4]Zhongshan Hospital, Fudan University, Shanghai, China[5]The First Affiliated Hospital of Soochow University, Suzhou, China[6]The First Affiliated Hospital of Dalian Medical University, Dalian, China大连医科大学附属第一医院[7]Qinghai Provincial People’s Hospital, Xining, China[8]West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[9]Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China华中科技大学同济医学院附属协和医院[10]The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China[11]Harbin the Fourth Hospital, Harbin, China[12]Northern Jiangsu People’s Hospital, Yangzhou, China江苏省人民医院[13]The First Affiliated Hospital of Nanchang University, Nanchang, China[14]The First Hospital of Chinese Medical University, Shenyang, China[15]Xijing Hospital, The Fourth Military Medical University, Xi’an, China[16]Nanfang Hospital, Nanfang Medical University, Guangzhou, China[17]Xinqiao Hospital, The Third Military Medical University, Chongqing, China[18]Peking University People’s Hospital, Beijing, China[19]Sichuan Provincial People’s Hospital, Chengdu, China四川省人民医院[20]Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[21]People’s Hospital of Xinjiang Uygur Autonomous Region, Ürümqi, China[22]Hainan Provincial People’s Hospital, Haikou, China[23]Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, China[24]Affiliated Hospital of North China University of Science and Technology, Tangshan, China[25]Union Hospital of Fujian Medical University, Fuzhou, China[26]The Second Hospital of Shanxi Medical University, Taiyuan, China[27]Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China[28]The First People’s Hospital of Yunnan Province, Kunming, China云南省第一人民医院[29]The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China[30]The Second Xiangya Hospital, Central South University, Changsha, China[31]Anhui Provincial Hospital, Hefei, China[32]Henan Cancer Hospital, Zhengzhou, China河南省肿瘤医院[33]Chengdu Women and Children’s Hospital, Chengdu, China[34]Nanjing Drum Tower Hospital, Nanjing, China[35]The Second Affiliated Hospital of Kunming Medical University, Kunming, China[36]Chinese PLA General Hospital, Beijing, China
Primary immune thrombocytopenia (ITP) is a bleeding disorder commonly encountered in clinical practice. The International Working Group (IWG) on ITP has published several landmark papers on terminology, definitions, outcome criteria, bleeding assessment, diagnosis, and management of ITP. The Chinese consensus reports for diagnosis and management of adult ITP have been updated to the 4th edition. Based on current consensus positions and new emerging clinical evidence, the thrombosis and hemostasis group of the Chinese Society of Hematology issued Chinese guidelines for management of adult ITP, which aim to provide evidence-based recommendations for clinical decision making.
第一作者机构：[1]Department of Hematology, Qilu Hospital, Shandong University, Jinan 250012, China
通讯作者：
推荐引用方式(GB/T 7714)：
Xin‑guang Liu,Xiao‑chuan Bai,Fang‑ping Chen,et al.Chinese guidelines for treatment of adult primary immune thrombocytopenia[J].INTERNATIONAL JOURNAL OF HEMATOLOGY.2018,107(6):615-623.doi:10.1007/s12185-018-2445-z.
APA：
Xin‑guang Liu,Xiao‑chuan Bai,Fang‑ping Chen,Yun‑feng Cheng,Ke‑sheng Dai...&Ming Hou.(2018).Chinese guidelines for treatment of adult primary immune thrombocytopenia.INTERNATIONAL JOURNAL OF HEMATOLOGY,107,(6)
MLA：
Xin‑guang Liu,et al."Chinese guidelines for treatment of adult primary immune thrombocytopenia".INTERNATIONAL JOURNAL OF HEMATOLOGY 107..6(2018):615-623
